Sam Chun Dang Pharm. Co. Ltd (000250) — Capital Reinvestment Ratio
Sam Chun Dang Pharm. Co. Ltd (000250) has a Capital Reinvestment Ratio of 1.86x as of June 2026, meaning it reinvests 2% of its operating cash flow (₩12.04 Billion) in capital expenditures (₩22.36 Billion). Check how tangible is Sam Chun Dang Pharm. Co. Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sam Chun Dang Pharm. Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Sam Chun Dang Pharm. Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Sam Chun Dang Pharm. Co. Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd from 2012 to 2025. See 000250 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.08x | ₩9.79 Billion | ₩59.59 Billion | ▲ +220.7% |
| 2024 | 1.90x | ₩21.77 Billion | ₩41.30 Billion | ▲ +102.3% |
| 2023 | 0.94x | ₩23.43 Billion | ₩21.97 Billion | ▼ -73.2% |
| 2022 | 3.51x | ₩13.28 Billion | ₩46.55 Billion | ▲ +31.3% |
| 2020 | 2.67x | ₩3.25 Billion | ₩8.68 Billion | ▲ +1139.4% |
| 2019 | 0.22x | ₩30.60 Billion | ₩6.59 Billion | ▼ -53.3% |
| 2018 | 0.46x | ₩25.03 Billion | ₩11.55 Billion | ▲ +270.1% |
| 2017 | 0.12x | ₩26.09 Billion | ₩3.25 Billion | ▼ -75.7% |
| 2016 | 0.51x | ₩17.76 Billion | ₩9.11 Billion | ▼ -19.0% |
| 2015 | 0.63x | ₩17.34 Billion | ₩10.97 Billion | ▲ +41.9% |
| 2014 | 0.45x | ₩19.55 Billion | ₩8.72 Billion | ▲ +65.9% |
| 2013 | 0.27x | ₩15.94 Billion | ₩4.28 Billion | ▼ -84.9% |
| 2012 | 1.79x | ₩1.60 Billion | ₩2.86 Billion | — |